US5118667A - Bone growth factors and inhibitors of bone resorption for promoting bone formation - Google Patents

Bone growth factors and inhibitors of bone resorption for promoting bone formation Download PDF

Info

Publication number
US5118667A
US5118667A US07/695,310 US69531091A US5118667A US 5118667 A US5118667 A US 5118667A US 69531091 A US69531091 A US 69531091A US 5118667 A US5118667 A US 5118667A
Authority
US
United States
Prior art keywords
bone
inhibitor
method
growth factor
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US07/695,310
Inventor
Steven W. Adams
Rosa Armstrong
David Rosen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Celtrix Pharmaceuticals Inc
Original Assignee
Celtrix Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celtrix Pharmaceuticals Inc filed Critical Celtrix Pharmaceuticals Inc
Priority to US07/695,310 priority Critical patent/US5118667A/en
Assigned to CELTRIX LABORATORIES, INC. A CORPORATION OF DE reassignment CELTRIX LABORATORIES, INC. A CORPORATION OF DE ASSIGNMENT OF ASSIGNORS INTEREST. Assignors: ADAMS, STEVEN W., ARMSTRONG, ROSA, ROSEN, DAVID
Application granted granted Critical
Publication of US5118667A publication Critical patent/US5118667A/en
Assigned to CELTRIX PHARMACEUTICALS, INC. reassignment CELTRIX PHARMACEUTICALS, INC. CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: CELTRIX LABORATORIES, INC.
Anticipated expiration legal-status Critical
Application status is Expired - Lifetime legal-status Critical

Links